International Stem Cell Corporation, announced today that it had entered into a jotting of reasoning with ARG Vermogensverwaltung AG, a German bail Fund, to create a new catalan accessory ("ISCO Europe") to be funded with up to $10 million of capital derived from ARG and other unconstrained sources in Europe. Shares of ISCO Europe are expected to trade on the Deutsche Bourse independently of the company's shares in the US. ISCO Europe's shares will not be convertible into ISCO shares on any US exchange.

More: - Brought to my attention by